Prevention of Late-Onset Cytomegalovirus Infection and Disease in Donor-Positive/Recipient-Negative Kidney Transplant Recipients Using Low-Dose Valganciclovir

2018 ◽  
Vol 50 (1) ◽  
pp. 124-129 ◽  
Author(s):  
K. Nanmoku ◽  
T. Shinzato ◽  
T. Kubo ◽  
T. Shimizu ◽  
T. Kimura ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Cytomegalovirus Infection ◽  
Low Dose ◽  
Late Onset ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients

Risk Factors for Late-Onset Cytomegalovirus Infection or Disease in Kidney Transplant Recipients

2014 ◽  
Vol 97 (5) ◽  
pp. 569-575 ◽  
Author(s):  
Alainna J. Jamal ◽  
Shahid Husain ◽  
Yanhong Li ◽  
Olusegun Famure ◽  
S. Joseph Kim
Keyword(s):  
Risk Factors ◽  
Kidney Transplant ◽  
Cytomegalovirus Infection ◽  
Late Onset ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients

CONTROLLED TRIAL OF IL2R ANTIBODY BASILIXIMAB (SIMULECT) VS LOW DOSE OKT3 IN CADAVER KIDNEY TRANSPLANT RECIPIENTS.

2000 ◽  
Vol 69 (Supplement) ◽  
pp. S156 ◽  
Author(s):  
Hamid Shidban ◽  
M. Sabawi ◽  
S. Aswad ◽  
G. Chambers ◽  
I. Castillon ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Low Dose ◽  
Controlled Trial ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Cadaver Kidney

Reduction in late onset cytomegalovirus primary disease after discontinuation of antiviral prophylaxis in kidney transplant recipients treated with de novo everolimus

2018 ◽  
Vol 20 (2) ◽  
pp. e12846 ◽  
Author(s):  
Arnaud Devresse ◽  
Marianne Leruez-Ville ◽  
Anne Scemla ◽  
Véronique Avettand-Fenoel ◽  
Lise Morin ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
De Novo ◽  
Late Onset ◽  
Antiviral Prophylaxis ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Primary Disease
Sign in / Sign up

Export Citation Format

Share Document